AVITA Medical Inc (NASDAQ:RCEL)
| 13.69 Delayed Data As of Jun 02 |  +1.27 / +10.23%Today’s Change | 4.41 Today|||52-Week Range 16.89 | +107.42% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $346.5M |
Company Description
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Contact Information
AVITA Medical, Inc. 28159 Avenue Stanford Valencia California 91355 |
Employees
Shareholders
| Mutual fund holders | 7.60% |
| Individual stakeholders | 2.58% |
| Other institutional | 14.87% |
Top Executives
| James M. Corbett | President, CEO & Executive Director |
| David Fencil | Senior Vice President-Global Operations |
| Sean Atkins | Chief Financial Officer & Senior VP-Finance |
| Andrew Quick | Chief Technology Officer |
| Debbie Garner | Senior Vice President-Global Marketing & Strategy |
